Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1990 May;66(775):387–388. doi: 10.1136/pgmj.66.775.387

Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction.

K G Oldroyd 1, R S Hornung 1, A M Jones 1, N P Andrews 1, P T Dawes 1, P H Carson 1
PMCID: PMC2426857  PMID: 2371191

Abstract

Two cases of haemarthrosis following thrombolytic therapy for acute myocardial infarction are described. Both patients had active pre-existing inflammatory disease in the affected joints at the time of presentation. This complication of thrombolytic therapy has not been previously reported.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andes W. A., Edmunds J. O. Hemarthroses and warfarin: joint destruction with anticoagulation. Thromb Haemost. 1983 Jun 28;49(3):187–189. [PubMed] [Google Scholar]
  2. Basu D., Gallus A., Hirsh J., Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med. 1972 Aug 17;287(7):324–327. doi: 10.1056/NEJM197208172870703. [DOI] [PubMed] [Google Scholar]
  3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988 Aug 13;2(8607):349–360. [PubMed] [Google Scholar]
  4. Salzman E. W., Deykin D., Shapiro R. M., Rosenberg R. Management of heparin therapy: Controlled prospective trial. N Engl J Med. 1975 May 15;292(20):1046–1050. doi: 10.1056/NEJM197505152922002. [DOI] [PubMed] [Google Scholar]
  5. TAIT G. B., BACH F., DIXON J. ACUTE SYNOVIAL RUPTURE: FURTHER OBSERVATIONS. Ann Rheum Dis. 1965 May;24:273–277. doi: 10.1136/ard.24.3.273. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES